Submitted by James Cantwell on Wed, 15/01/2025 - 10:38
The anticipatory prescribing of injectable medications is a common practice to manage symptoms for people receiving end-of-life care at home or in care homes. Despite its widespread use, there is limited evidence into acceptability, safety and clinical effectiveness of anticipatory prescribing.
In this resource for healthcare professionals and applied researchers, Dr. Ben Bowers and colleagues share key findings from their extensive research covering topics such as reviewing the existing evidence base, changes in practice since the COVID-19 pandemic, the varying perspectives from people involved in this process, the financial costs of this medication, and solutions for system-level change.
You can access the resource here.